{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:01:24Z","timestamp":1785265284004,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jaut.2013.07.008","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T02:02:08Z","timestamp":1376359328000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by\u00a0the protein kinase inhibitor sorafenib"],"prefix":"10.1016","volume":"46","author":[{"given":"Yan-Ru","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Di","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Song","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mae","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Xiong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2013.07.008_bib1","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis\u2013from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.07.008_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2005.06.014","article-title":"Mechanisms of liver fibrosis","volume":"364","author":"Shigeki","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jaut.2013.07.008_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2013.07.008_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gut.50.6.891","article-title":"Transcriptional regulation of hepatic stellate cell activation","volume":"50","author":"Mann","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.07.008_bib5","doi-asserted-by":"crossref","first-page":"11721","DOI":"10.1074\/jbc.M207728200","article-title":"Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells\u2013constitutive nuclear localization of Smads in activated cells is TGF-beta-independent","volume":"278","author":"Liu","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaut.2013.07.008_bib6","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1111\/j.1440-1746.2006.04659.x","article-title":"Molecular mechanisms of hepatic fibrogenesis","volume":"22","author":"Parsons","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2013.07.008_bib7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10495-005-1055-4","article-title":"The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis","volume":"10","author":"Elsharkawy","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.jaut.2013.07.008_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2001-17558","article-title":"Hepatic stellate cells as a target for the treatment of liver fibrosis","volume":"21","author":"Bataller","year":"2001","journal-title":"Semin Liver Dis"},{"issue":"III\u2013XIII","key":"10.1016\/j.jaut.2013.07.008_bib9","first-page":"1","article-title":"Cooperation of liver cells in health and disease","volume":"161","author":"Kmiec","year":"2001","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"10.1016\/j.jaut.2013.07.008_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/1566524033479528","article-title":"Mechanisms of liver injury: an overview","volume":"3","author":"Higuchi","year":"2003","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jaut.2013.07.008_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.20051","article-title":"Apoptosis: the nexus of liver injury and fibrosis","volume":"39","author":"Canbay","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib12","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1053\/j.gastro.2011.03.006","article-title":"Targeted therapies for hepatocellular carcinoma","volume":"140","author":"Villanueva","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.07.008_bib13","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/hep.24644","article-title":"Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy","volume":"54","author":"Iavarone","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.07.008_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd2130","article-title":"Discovery and development of sorafenib: a multikinase inhibitor for treating cancer","volume":"5","author":"Wilhelm","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaut.2013.07.008_bib16","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaut.2013.07.008_bib17","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1158\/1078-0432.CCR-09-3389","article-title":"Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3","volume":"16","author":"Chen","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaut.2013.07.008_bib18","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1158\/1535-7163.MCT-08-0138","article-title":"Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas","volume":"7","author":"Yang","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jaut.2013.07.008_bib19","first-page":"408","article-title":"Sorafenib downregulates ERK\/Akt and STAT3 survival pathways and induces apoptosis in a human neuroblastoma cell line","volume":"3","author":"Chai","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jaut.2013.07.008_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.7.536","article-title":"Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target","volume":"7","author":"Wang","year":"2011","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jaut.2013.07.008_bib21","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.2353\/ajpath.2010.090469","article-title":"Lack of glycoprotein 130\/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis","volume":"176","author":"Plum","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2013.07.008_bib22","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1053\/j.gastro.2010.02.049","article-title":"Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis","volume":"138","author":"Mair","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.07.008_bib23","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/hep.23532","article-title":"Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice","volume":"51","author":"Horiguchi","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2009.06.024","article-title":"Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats","volume":"51","author":"Reiberger","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.07.008_bib25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","article-title":"New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis","volume":"53","author":"Wang","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.07.008_bib27","first-page":"257","article-title":"Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in\u00a0vivo","volume":"58","author":"Hong","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaut.2013.07.008_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.24427","article-title":"Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis","volume":"54","author":"Thabut","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib29","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/hep.24254","article-title":"Sorafenib inhibits transforming growth factor beta1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes","volume":"53","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib30","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.4049\/jimmunol.178.7.4548","article-title":"Recognition of double-stranded RNA by TLR3 induces severe small intestinal injury in mice","volume":"178","author":"Zhou","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.07.008_bib31","first-page":"718","volume":"40","author":"Schumann","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jaut.2013.07.008_bib32","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2004.04.062","article-title":"Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes","volume":"127","author":"Safadi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.07.008_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hep.24621","article-title":"Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression","volume":"55","author":"Jiao","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.510230544","article-title":"Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid","volume":"23","author":"Van Rooijen","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib35","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/onc.2009.308","article-title":"The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression","volume":"29","author":"Luo","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jaut.2013.07.008_bib36","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/j.gastro.2008.01.016","article-title":"Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury","volume":"134","author":"Horiguchi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.07.008_bib37","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hep.510230648","article-title":"Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration","volume":"23","author":"Vrochides","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.07.008_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1634\/theoncologist.2008-0281","article-title":"Commentary: sorafenib use in patients with advanced hepatocellular carcinoma and underlying child-pugh b cirrhosis-evidence and controversy","volume":"14","author":"Zhu","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.jaut.2013.07.008_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1634\/theoncologist.2008-0191","article-title":"Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis","volume":"14","author":"Pinter","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.jaut.2013.07.008_bib41","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/cncr.24029","article-title":"Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response","volume":"115","author":"Yau","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jaut.2013.07.008_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaut.2013.07.008_bib43","first-page":"361","article-title":"Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide","volume":"25","author":"Casini","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib44","first-page":"919","article-title":"Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation","volume":"38","author":"Vinas","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/intimm\/dxq030","article-title":"IL-6: from its discovery to clinical applications","volume":"22","author":"Kishimoto","year":"2010","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaut.2013.07.008_bib46","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/hep.23214","article-title":"Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2","volume":"50","author":"Blechacz","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.008_bib47","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/hep.26328","article-title":"Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells","volume":"57","author":"Sprinzl","year":"2013","journal-title":"Hepatology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113001042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113001042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:08:55Z","timestamp":1760256535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841113001042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":47,"alternative-id":["S0896841113001042"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2013.07.008","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by\u00a0the protein kinase inhibitor sorafenib","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2013.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}